Can long term acyclovir use affect the nervous system?

Can long term acyclovir use affect the nervous system?

Acyclovir can reach the central nervous system when given in high intravenous doses, and case reports describe confusion, tremors, and hallucinations in patients with reduced kidney function. These neurologic effects usually appear within days and reverse after the drug is stopped.

What blood levels increase the risk of neurotoxicity?

Neurotoxicity is most common when acyclovir concentrations exceed 2 µg/mL, a level reached more often in people whose creatinine clearance is below 30 mL/min. Dose adjustment based on renal function is the main preventive step.

Does oral long-term suppression therapy carry the same risk?

Daily oral doses used for herpes suppression are much lower than intravenous regimens and rarely produce measurable central-nervous-system levels. Large cohort studies have not linked standard oral regimens to lasting neurologic deficits.

Are there reports of peripheral nerve problems with prolonged use?

Isolated case reports mention paresthesias or neuropathy during chronic oral therapy, but these events remain rare and lack clear causal proof. Larger surveillance data have not confirmed a consistent signal.

When does neurologic recovery occur after stopping acyclovir?

Most patients regain normal mental status within 48–72 hours once plasma levels fall. Dialysis can shorten recovery in severe overdoses.

Are there safer alternatives for patients with kidney disease?

Valacyclovir is converted to acyclovir but offers higher bioavailability, allowing lower tablet counts. For patients with severe renal impairment, famciclovir or topical agents may be considered instead.

How do clinicians monitor for early neurologic signs?

Baseline and periodic serum creatinine checks guide dose changes. Any new confusion or tremor in a treated patient prompts immediate drug-level review and possible discontinuation.

Does acyclovir have documented long-term neurologic safety data?

Observational registries spanning up to five years of continuous oral use have not identified cumulative neurotoxicity. Current labeling recommends caution mainly in the setting of acute kidney injury.